Please assess the completion status of the following clinical trial:

Trial Title: Acandis Credo Intracranial Stent for Unsuccessful Recanalization After Thrombectomy (ACUTE)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Acute ischemic stroke from large vessel occlusion (LVO)~* Failed recanalization after treatment with thrombectomy, i.e. persistent occlusion of intracranial internal carotid artery (ICA), proximal segment (M1, M2) of the middle cerebral artery (MCA) (TICI 0-1)~* Small to moderate infarct core prior to initiation of thrombectomy (CT ASPECTS 6-10, DWI lesion \< 70 ml)~* Suspected underlying stenosis of the occluded artery amenable to stenting by judgement of the treating neurointerventionalist~* Age 18- 80 years~* Informed consent (see below)~* Decision to perform angioplasty and stenting \< 12 hours of symptom onset~* Previous passage of occlusion with microcatheter obtained~Exclusion Criteria:~* Large infarct core prior to initiation of thrombectomy (CT ASPECTS 0-5, DWI lesion \> 70 ml)~* Vessel occlusion or stenosis of different known or suspected cause than atherosclerosis (e.g. vasculitis)~* Pre-stroke disability (MRS \> 2)~* Any sign of intracranial haemorrhage on brain imaging prior to thrombectomy~* Any sign of intracranial vessel perforation during thrombectomy~* Contraindication against treatment with double anti-platelet treatment~* Current effective use of oral anticoagulants (e.g. INR \> 1.7 for Vitamin K antagonists)~* More than 3 attempts for recanalization of target lesion prior to the use of the study device.~* Stenosis longer than the working length of the NeuroSpeed PTA balloon catheter.~* Diameter of the healthy vessel proximal and distal to the stenosis prevents save treatment with the NeuroSpeed PTA balloon catheter or is outside the indicated range of the Credo stent.~* Diameter of the target area is outside the indicated range of the Credo stent after predilation.~* Contraindication against anti-platelet or anticoagulation therapy~* Heavily calcified lesions that may prevent access or safe stent placement.~* Pregnant and breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- ACUTE (Type: OTHER): Patients with acute ischemic stroke and proven large vessel occlusion (e.g. intracranial internal carotid artery or middle cerebral artery) with unsuccessful recanalization after endovascular treatment with mechanical thrombectomy and suspected underlying stenosis of the occluded intracranial artery amenable to stenting based on judgment by the treating neurointerventionalist.

Based on this trial design, predict the completion outcome and termination type (if applicable).